Loading...
Loading...
Application UK00918034962 · Registered
| Application Number | UK00918034962 |
| Status | Registered |
| Owner | Curium Netherlands B.V. |
| Filed | 2019-03-13 |
| Registered | 2019-09-06 |
| Renewal Due | 2029-03-13 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. CURIUM PHARMA is currently a registered UK trademark, with renewal due on 2029-03-13. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Radiopharmaceutical preparations for use in nuclear medicine; Pharmaceutical kits for making radiopharmaceutical preparations.
Medical generators for use in the production and transportation of nuclear medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for administering radioactive medicine and imaging solutions in gaseous form for medical imaging procedures and component parts therefor; Elution shields, namely, nuclear medicine radiation apparatus for collection of sodium-pertechnetate from Mo99/Tc99m generators and radiation shielding.
'CURIUM PHARMA' is a registered trademark on the UK IPO register, owned by Curium Netherlands B.V.. The application (UK00918034962) was filed on 13 March 2019 and registered on 6 September 2019. The registration is set to expire on 13 March 2029.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus).
The trademark is represented by Dehns.
UK trademark UK00918034962 for the mark 'CURIUM PHARMA' in Class 5, 10 is recorded on the UK IPO register as owned by Curium Netherlands B.V.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00918034962 for the mark 'CURIUM PHARMA' as registered.
UK trademark UK00918034962 for the mark 'CURIUM PHARMA' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus). The filed specification reads: Class 5: Radiopharmaceutical preparations for use in nuclear medicine; Pharmaceutical kits for making radiopharmaceutical preparations. | Class 10: Medical generators for use in the production and transportation of nuclear medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for adminis…
UK trademark UK00918034962 for the mark 'CURIUM PHARMA' was filed at the UK IPO on 13 March 2019 and registered on 6 September 2019.
UK trademark UK00918034962 for the mark 'CURIUM PHARMA' is currently recorded as valid until 13 March 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Dehns is listed as the attorney / representative of record for UK trademark UK00918034962 for the mark 'CURIUM PHARMA' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.